SIRIANNI, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 7.067
AS - Asia 5.309
EU - Europa 3.687
SA - Sud America 1.476
AF - Africa 319
Continente sconosciuto - Info sul continente non disponibili 181
OC - Oceania 20
AN - Antartide 1
Totale 18.060
Nazione #
US - Stati Uniti d'America 6.754
SG - Singapore 2.089
BR - Brasile 1.058
CN - Cina 993
UA - Ucraina 982
VN - Vietnam 902
DE - Germania 690
IT - Italia 666
AT - Austria 332
BD - Bangladesh 266
FR - Francia 264
SE - Svezia 243
IN - India 218
CA - Canada 170
FI - Finlandia 153
TR - Turchia 143
AR - Argentina 138
KR - Corea 114
HK - Hong Kong 113
SN - Senegal 107
GB - Regno Unito 91
IQ - Iraq 80
ZA - Sudafrica 80
MX - Messico 70
CO - Colombia 65
ID - Indonesia 61
RU - Federazione Russa 59
EC - Ecuador 57
CL - Cile 44
PK - Pakistan 44
MA - Marocco 40
NL - Olanda 39
VE - Venezuela 34
BE - Belgio 32
PY - Paraguay 30
MY - Malesia 27
UZ - Uzbekistan 26
AE - Emirati Arabi Uniti 23
JP - Giappone 22
SA - Arabia Saudita 22
PE - Perù 20
PH - Filippine 20
PL - Polonia 20
ES - Italia 19
AU - Australia 18
UY - Uruguay 18
EG - Egitto 17
AZ - Azerbaigian 16
DZ - Algeria 15
JO - Giordania 15
LT - Lituania 15
TN - Tunisia 15
EU - Europa 13
BO - Bolivia 12
JM - Giamaica 12
KE - Kenya 12
NP - Nepal 12
PS - Palestinian Territory 12
CZ - Repubblica Ceca 11
ET - Etiopia 11
LB - Libano 11
AL - Albania 10
BH - Bahrain 10
IL - Israele 10
OM - Oman 10
SK - Slovacchia (Repubblica Slovacca) 9
CR - Costa Rica 8
DO - Repubblica Dominicana 8
HN - Honduras 8
TH - Thailandia 8
GE - Georgia 7
PA - Panama 7
BB - Barbados 6
IE - Irlanda 6
KG - Kirghizistan 6
KZ - Kazakistan 6
NI - Nicaragua 6
MD - Moldavia 5
TT - Trinidad e Tobago 5
AO - Angola 4
BG - Bulgaria 4
BY - Bielorussia 4
CH - Svizzera 4
CY - Cipro 4
EE - Estonia 4
RS - Serbia 4
SY - Repubblica araba siriana 4
DK - Danimarca 3
GA - Gabon 3
GT - Guatemala 3
HU - Ungheria 3
IR - Iran 3
NG - Nigeria 3
PR - Porto Rico 3
RO - Romania 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BZ - Belize 2
CG - Congo 2
Totale 17.856
Città #
Singapore 803
Chandler 765
Jacksonville 565
Dallas 524
San Jose 491
Ashburn 443
Council Bluffs 382
San Mateo 376
Boardman 333
Ho Chi Minh City 308
Beijing 282
Dearborn 276
New York 243
Vienna 223
Rende 209
Hanoi 185
Lawrence 136
Roxbury 136
Lauterbourg 128
Shanghai 123
São Paulo 117
Helsinki 115
Seoul 113
Izmir 108
Dakar 107
Hong Kong 101
Ottawa 91
Des Moines 88
Munich 84
Los Angeles 74
Santa Clara 73
Cambridge 70
Grafing 66
Hefei 61
Brooklyn 57
Da Nang 51
Haiphong 44
Milan 44
Columbus 41
Orem 41
Bremen 40
Rome 39
Ann Arbor 37
Turku 37
Wilmington 37
Johannesburg 35
Frankfurt am Main 34
Omaha 34
Ogden 33
Inglewood 32
Toronto 32
Brussels 31
Rio de Janeiro 31
Guangzhou 30
Phoenix 28
Seattle 28
London 27
Baghdad 26
San Francisco 26
Tashkent 25
Pune 24
The Dalles 23
Hanover 22
Redwood City 22
Hải Dương 21
Quito 21
Dhaka 20
Guayaquil 20
Mumbai 20
Tokyo 20
Biên Hòa 19
Guarulhos 19
Amsterdam 18
Brasília 18
Chicago 18
Porto Alegre 18
Montreal 17
Chennai 16
Medellín 16
Mexico City 16
Montevideo 16
Naples 16
Santiago 16
Tianjin 16
Catanzaro 15
Cosenza 15
Curitiba 15
Lahore 15
Ninh Bình 15
Amman 14
Bogotá 14
Florence 14
Houston 14
Palermo 14
Recife 14
Baku 13
Belo Horizonte 13
Buenos Aires 13
Campinas 13
Casablanca 13
Totale 9.795
Nome #
6,6A-DIHYDRO FURO[3,2-B]FURAN-2-(5H)ONE DERIVATIVES, THEIR PREPARATION AND USE FOR TREATING TUMORS 266
Antioxidant activity of a mediterranean food product: "fig syrup" 232
17 β-estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocytes-derived cell line. 232
6-substituted carbazoles: synthesis and biological evaluation 228
Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment 226
A resveratrol derivative induces authophagic cell death in human breast cancer MCF-7 cell line. 226
Aromatase expression in prepuberal Sertoli cells: Effect of thyroid hormone 216
27-hydroxycholesterol promotes adrenocortical cancer progression. 210
27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer 206
DAX-1, as an androgen-target gene, inhibits aromatase expression: A novel mechanism blocking estrogendependent breast cancer cell proliferation 202
Estrogen related receptor a (ERRa) a promising target for the therapy of adrenocortical carcinoma (ACC) 202
" L'attività antiproliferativa dell'oleuropeina e dell'idrossitirisolo nelle cellule di carcinoma mammario MCF-7 è associata all'inibizione delle MAP chinasi." 201
Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines 195
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 194
Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: Part i 191
A novel interplay between AR and DAX-1 controls aromatase expression in estrogen-dependent cancers 190
Adrenocortical Carcinoma (ACC) Cells Rewire Their Metabolism to Overcome Curcumin Antitumoral Effects Opening a Window of Opportunity to Improve Treatment 187
Cholesterol as an endogenous ERRα agonist: A new perspective to cancer treatment 185
Activation of GPER induces apoptosis in adrenocortical cancer (ACC) cells and controls tumor growth in vivo 184
Activation of G-Protein-Coupled Estrogen Receptor (GPER) inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new target for ACC treatment. 184
Cyclooxygenase (Cox)-2 regulating transcriptional and post-transcriptional activation of aromatase is involved in Leydig cell tumor proliferation 179
17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line 178
A role of Src-tyrosine kinase in adrenal aldosterone production 177
17β-Estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ERα 175
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 174
Aromatase expression in prepuberal Sertoli cells: effects of thyroid hormone 172
A targetable antioxidant defense mechanism to EZH2 inhibitors enhances tumor cell vulnerability to ferroptosis 170
Cholesterol as new target for ACC therapy. 170
Antitumoral activities of curcumin and recent advances to improve its oral bioavailability 168
ERRα/PGC1α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical carcinoma (ACC). 162
17β-estradiol induces expression of apoptotic markers through activation of GPR30 pathway in rat Pachytene Spermatocytes 161
Aromatase expression in peripuberal Sertoli cells:: effect of thyroid hormone 160
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo 154
ERRα/PGC1-α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical cancer (ACC) 154
Catalytic Double Cyclization Process for Antitumor Agents against Breast Cancer Cell Lines 154
Defining the pathway responsible for Leydig cell tumors: the role of IGF-I and estrogens. 153
Inhibition of cholesterol synthesis by simvastatin reduces ACC growth interfering with the regulation of mitochondrial respiratory chain mediated by estrogens/estrogen receptor alpha. 153
A role for src tyrosine kinase in regulating adrenal aldosterone production 150
Statins reduce intratumor cholesterol affecting adrenocortical cancer growth 149
The AP-1 family member Fos blocks transcriptional activity of the nuclear receptor steroidogenic factor 1 143
SIRT1 is involved in adrenocortical cancer growth and motility 142
Cross talk of estrogen (E2) and IGF-II signalling in adrenocortical tumor cell proliferation. 141
27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth 139
Cyclooxygenase-2 (COX-2) inhibitors down-regulate aromatase expression and inhibit proliferation of tumor Leydig cells 139
1α,25-Dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: A model for a protective role of vitamin D receptor against adrenocortical cancer 139
Nandrolone and Stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation 139
Synthesis of a new bis(indolyl)methane that inhibits growth and induces apoptosis in human prostate cancer cells 139
Resveratrol and Its Analogs As Antitumoral Agents For Breast Cancer Treatment 137
Cross-talk between estrogen and IGF-II signalling in adrenocortical tumor cell proliferation. 137
XCT790 an inverse agonist of estrogen related receptor alpha (ERRalpha) inhibits cellular metabolism, motility and invasion of adrenocortical cancer cell line H295R. 136
Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer 134
Foxo3a inhibits tamoxifen-resistant breast cancer progression by inducing integrin α5 expression 134
Inhibition of Leydig tumor growth by Farnesoid X Receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy 133
Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers 133
Effects of tri-iodothyronine on alternative splicing events in the coding region of cytochrome P450 aromatase in immature rat Sertoli cells 130
Androgens Modulate Bcl-2 Agonist of Cell Death (BAD) Expression and Function in Breast Cancer Cells 129
Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells 129
Potential of Olive oil Phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies 129
Ruolo dei recettori nucleari orfani SF-1, LRH-1, SHP e DAX-1 nella regolazione dell’espressione dell'aromatasi in cellule testicolari 128
DAX-1 at the Crossroads Between Androgens and Aromatase: A Novel Mechanism in the Inhibition of Estrogen-Dependent Cancer Cell Proliferation 128
Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol 127
GPER Signaling in Spermatogenesis and Testicular Tumors 126
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new therapy for ACC 124
Antiestrogens upregulate estrogen receptor β expression and inhibit adrenocortical H295R cell proliferation 124
Human sperm liver receptor homolog-1 (LRH-1) acts as a downstream target of the estrogen signaling pathway 123
Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system 122
GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway 121
Central role of estrogen receptor α in adrenocortical tumor cell proliferation. 121
Gper and ESRs are expressed in rat round spermatids and mediate oestrogen-dependent rapid pathways modulating expression of cyclin B1 and Bax 120
Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression 119
Derivati 6,6A-Diidrofuro[3,2-b]furan-2-(5H)onici, loro preparazione e uso nel trattamento dei tumori 117
“Involment of orphan nuclear receptors SF-1, LRH-1, DAX-1 and SHP in regulation of aromatase expression in Leydig cells”. 116
Il Recettore Nucleare Orfano Liver Receptor Homologue (LRH) regola la trascrizione di geni codificanti per enzimi steroidogenici 115
The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17β-estradiol on mouse spermatogonial GC-1 cell line 115
Estrogen Related Receptor α (ERRα) As Potential Target for a New Adrenocortical Carcinoma (ACC) Therapy 115
Oleuropeina ed idrossitirisolo attivano pathways GPER-dipendenti inducendo apoptosi in cellule tumorali mammarie SKBR3 negative per i recettori estrogenici α e β. 115
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to inhibit growth and invasion of adrenocortical carcinoma (ACC) Università della Calabria 114
Antiestrogens ICI 182,780 and 4-hydroxytamoxifen upregulate Erb expression and inhibit human adrenocortical cancer proliferation. 113
Involvment of Cyclooxygenase-2 (COX-2) in regulating estrogen-dependent Leydig cell tumor proliferation 112
Inhibition of Src tyrosine kinase stimulates adrenal androgen production 112
Differential expression of steroidogenic factor-1/adrenal 4 binding protein and liver receptor homolog-1 (LRH-1)/fetoprotein transcription factor in the rat testis: LRH-1 as a potential regulator of testicular aromatase expression 110
Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: Potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment 110
Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells 110
Characterization of olive flower phenolic extract (OFE) and its anti-proliferative activity on MCF-7 Human Breast Cancer Cells. 110
The metabolic regulator estrogen-related receptor alpha as a therapeutic target in Adrenocortical Carcinoma (ACC). 110
Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor leydig cell proliferation 109
Mitotane activates GPER-dependent pathways leading to apoptosis of human adrenocortical carcinoma H295R cell line. 108
Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation 106
G protein-coupled estrogen receptor-1 (GPER1)- and estrogen receptor α (ESR1)- dependent pathways regulate spermatocytes apoptosis. 106
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 104
Rapid estrogen signaling in spermatogenesis 103
Steroid Receptor Signaling as Targets for Resveratrol Actions in Breast and Prostate Cancer 103
Food System Transformation and Gut Microbiota Transition: Evidence on Advancing Obesity, Cardiovascular Diseases, and Cancers-A Narrative Review 102
The novel estrogen receptor GRP30 mediates the proliferatiive effects induced by 17beta-estradiol onGC-1 mouse spermatogonial cell line 102
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to fight adrenocortical carcinoma (ACC) progression and as useful tool to determine ACC stem cell-like proprieties. 100
L’attivazione selettiva di GPER inibisce la proliferazione e attiva l’apoptosi in cellule di Leydig tumorali. 99
GPR30 mediates estradiol-proliferative effects on GC-1 mouse spermatogonial cell line through ERK/Fos activation 98
The Estrogen Related Receptor α (ERRα) inverse agonist XCT-790 reduces adrenocortical cancer (ACC) H295R cells growth in vitro and in vivo. 97
Role of IGF-I and estrogens in Leydig cell tumorogenesis. 97
Role of scaffold protein Proline-, Glutamic acid-, and Leucine-Rich protein 1 (PELP1) in the modulation of adrenocortical cancer cell growth 96
Totale 14.559
Categoria #
all - tutte 98.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.452 0 0 10 82 203 74 17 410 18 16 189 433
2022/20231.832 244 251 126 219 252 155 14 185 195 56 73 62
2023/20241.154 119 50 77 55 67 313 38 43 77 52 40 223
2024/20252.394 163 330 77 135 155 105 59 145 451 189 247 338
2025/20267.721 879 306 850 647 1.385 493 812 403 586 565 364 431
2026/2027543 362 125 56 0 0 0 0 0 0 0 0 0
Totale 18.060